LumenFocus selected to participate in rapid decontamination prototype program |
LumenFocus announced that the Department of Defense (DoD) has selected the company for participation in a multi-team advanced medical prototype development program with an award of $2.3 million. The current COVID-19 crisis highlights the need for rapid decontamination/disinfection of rooms and spaces in environments to mitigate the spread of disease or infection. Decontamination/disinfection, and subsequent reduced spread of respiratory disease, promotes continuity of military operations, mission readiness, and individual warfighter survivability. To address this need, LumenFocus, LLC is providing prototypes to support the configuration, installation and testing of their existing and proven commercial UV solutions in various environments. LumenFocus products make use of UV technologies, and UV spectrums to render pathogens harmless.
“As an American company, we are thrilled at the opportunity to be developing products to help our servicemen and servicewomen,” said Charles Kassay, LumenFocus CEO. “We are looking forward to working with the DIU to get these germicidal UV products tested and deployed to help keep our fellow Americans safe and healthy.”
The award was issued on behalf of the Naval Medical Research Center (NMRC) with support from Defense Innovation Unit (DIU) for a 24-month period of performance.